Internal Medicine, Rheumatology · Wichita, KS
NPI
1104206077
Since 2015
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1921 N Webb Rd
Wichita, KS, 67206
Phone (316) 612-4815
Groups this clinician bills Medicare through
Medicare paid, 2024
$913K
55,430 services
Medicare patients, 2024
450
Average age 72
Drug cost, 2024
$3.8M
4,633 prescriptions
Company payments, 2025
$1,036
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rawaa Ebrahem was code J1602 (injection, golimumab, 1 mg, for intravenous use), 23,064 times for 34 patients. In total Rawaa Ebrahem billed 55,430 services in 80 codes, and Medicare paid $913K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 23,064 | 34 | $8.86 | $204K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 6,075 | 21 | $33.82 | $205K |
| J0897 Injection, denosumab, 1 mg | Office | 5,880 | 64 | $20.43 | $120K |
| 99214 Office E&M - Established | Office | 651 | 323 | $84.64 | $55K |
| 80053 Clinical Chemistry | Office | 637 | 343 | $10.31 | $6,566 |
| 85025 Blood Count | Office | 624 | 335 | $7.56 | $4,716 |
| 36415 Venipuncture Blood Collection | Office | 571 | 330 | $8.61 | $4,916 |
| 85652 Clinical Chemistry | Office | 542 | 327 | $2.64 | $1,430 |
| 86140 Clinical Chemistry | Office | 540 | 325 | $5.05 | $2,727 |
| 96365 Intravenous Infusion, Hydration | Office | 223 | 62 | $44.39 | $9,900 |
| 86235 Immunoassay | Office | 161 | 23 | $17.57 | $2,829 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 111 | 38 | $0.73 | $81.47 |
| 96372 Injection Administration | Office | 102 | 66 | $10.54 | $1,075 |
| 86481 Immunoassay | Office | 88 | 84 | $98.00 | $8,624 |
| 82306 Clinical Chemistry | Office | 85 | 85 | $29.01 | $2,466 |
By year: 2022 $540K for 35,359 services; 2023 $857K for 44,073 services; 2024 $913K for 55,430 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 637 | 343 | $10.31 | $6,566 |
| 85025 Blood Count | 624 | 335 | $7.56 | $4,716 |
| 36415 Venipuncture Blood Collection | 571 | 330 | $8.61 | $4,916 |
| 85652 Clinical Chemistry | 542 | 327 | $2.64 | $1,430 |
| 86140 Clinical Chemistry | 540 | 325 | $5.05 | $2,727 |
| 86235 Immunoassay | 161 | 23 | $17.57 | $2,829 |
| 86481 Immunoassay | 88 | 84 | $98.00 | $8,624 |
| 82306 Clinical Chemistry | 85 | 85 | $29.01 | $2,466 |
| 86200 Immunoassay | 67 | 67 | $12.69 | $850 |
| 86431 Immunoassay | 65 | 65 | $5.56 | $361 |
Medicare prescription drug claims, 2024
In 2024, the drug Rawaa Ebrahem prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 966 prescriptions and refills. In total Rawaa Ebrahem wrote 4,633 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 966 | 1,246 | 185 | $13K |
| Sulfasalazine Generic | 598 | 746 | 122 | $8,584 |
| Hydroxychloroquine Sulfate Generic | 544 | 769 | 121 | $12K |
| Prednisone Generic | 404 | 475 | 174 | $1,337 |
| Gabapentin Generic | 243 | 329 | 52 | $2,278 |
| Celecoxib Generic | 226 | 327 | 54 | $7,014 |
| Diclofenac Sodium Generic | 157 | 178 | 36 | $1,517 |
| Humira(Cf) Pen Adalimumab | 156 | 156 | 23 | $1.1M |
| Folic Acid Generic | 121 | 260 | 32 | $771 |
| Alendronate Sodium Generic | 97 | 185 | 27 | $446 |
| Tramadol Hcl Generic | 92 | 92 | 22 | $443 |
| Leflunomide Generic | 89 | 155 | 27 | $3,958 |
| Duloxetine Hcl Generic | 88 | 120 | 18 | $1,313 |
| Enbrel Sureclick Etanercept | 77 | 77 | 15 | $566K |
| Cyclobenzaprine Hcl Generic | 69 | 75 | 20 | $722 |
Brand drugs: 1,169 claims; generic drugs: 3,464 claims; opioid claims: 94.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rawaa Ebrahem $1,036 ($1,036 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $338.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.